Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.On CNBC's "Mad Money Lightning Round," Jim Cramer said Reddit, Inc. (NYSE:RDDT) is "fabulous," adding that he is not a seller.
在CNBC的《疯狂金钱快闪》中，吉姆·克莱默表示，Reddit, Inc. (纽交所: RDDT) "非常好"，并补充说他不是卖出者。
According to a report last week, shareholder Advance Magazine Publishers, Inc. plans to establish a credit facility using its stake in the company. Yahoo Finance reported that the publishing company aims to make as much as $1.2 billion in a sale of 7.8 million shares for between $145.38 and $148.54 per share.
根据上周的一份报告，股东Advance Magazine Publishers, Inc.计划利用其在公司的股份建立信贷额度。Yahoo Finance报道，该出版公司计划通过以每股145.38美元至148.54美元的价格出售780万股，最多筹集12亿。
"I am concerned that many auto parts may be made in China, we don't know," Cramer said when asked about Aptiv PLC (NYSE:APTV). He recommended going with AutoZone (NYSE:AZO).
当被问及aptiv plc (纽交所: APTV)时，克莱默表示："我担心许多汽车零件可能是在中国制造的，我们不知道。"他建议选择汽车地带（纽交所: AZO）。
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.
11月21日，古根海姆分析师罗纳德·朱西科维维保持对aptiv的买入评级，并将目标价从87美元下调至73美元。
When asked about Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), he said, "Now, I think, at five, it's, it is worthwhile speculation."
当被问及Recursion Pharmaceuticals, Inc. (纳斯达克: RXRX)时，他表示："现在，我认为，以五来说，这是值得的投机。"
On Nov. 20, Needham analyst Gil Blum reiterated Recursion Pharmaceuticals with a Buy and maintained a price target of $11.
11月20日，Needham分析师吉尔·布卢姆重申对Recursion Pharmaceuticals的买入评级，并维持11美元的目标价。
"Not enough specialty," Cramer said when asked about ZoomInfo Technologies Inc. (NASDAQ:ZI). "Let's pass on that."
"特色不够，"克莱默在被问及zoominfo technologies inc. (纳斯达克: ZI)时表示。"我们就不跟了。"
On Nov. 12, ZoomInfo Technologies reported better-than-expected earnings for its third quarter.
在11月12日，zoominfo technologies报告了其第三季度的业绩好于预期。
Dow Inc. (NYSE:DOW) is a "tough" one, the "Mad Money" host said. "If you don't have growth, and you sell at 21 times earnings, you're not going to be able to do anything."
陶氏化学生意（纽交所:DOW）是一个"艰难"的选择，"疯狂金钱"主持人表示。"如果你没有增长，而你的市盈率是21倍，那么就没办法做任何事情。"
On Nov. 8, Piper Sandler analyst Charles Neivert maintained Dow with an Overweight rating and lowered the price target from $62 to $60.
11月8日，派杰投资分析师查尔斯·奈弗特对陶氏维持了超重评级，并将目标价格从62美元下调至60美元。
Cramer said, "Accounting irregularities equal sell," when asked about Super Micro Computer (NASDAQ:SMCI).
克拉默在被问及超微电脑（纳斯达克:SMCI）时表示，"会计不规范等于卖出。"
Super Micro Computer experienced a significant stock decline on Tuesday, after announcing the termination of two critical loan agreements with major financial institutions.
超微电脑宣布终止与主要金融机构的两项关键贷款协议后，周二股价大幅下跌。
Price Action:
价格行动：
- Aptiv shares fell 3.2% to settle at $55.28 on Tuesday.
- Reddit shares fell 4.4% to close at $135.61.
- Recursion Pharmaceuticals shares declined 1.8% to close at $5.89.
- ZoomInfo shares gained 0.2% to close at $10.89.
- Dow shares fell 2.9% to settle at $44.54 on Tuesday.
- Super Micro Computer shares dipped 10.4% to settle at $34.43 during the session.
- aptiv plc的股票周二下跌3.2%，收于55.28美元。
- Reddit的股票下跌4.4%，收于135.61美元。
- Recursion Pharmaceuticals的股票下跌1.8%，收于5.89美元。
- zoominfo的股价上涨了0.2%，收于10.89美元。
- 陶氏化学的股价下跌了2.9%，在周二收于44.54美元。
- 超微电脑的股价在交易中下跌了10.4%，收于34.43美元。
- Jim Cramer: Linde Is A 'Terrific' Company, Sees Another Stock Up 75% As 'Not Done'
- 吉姆·克莱默：linde是一家“优秀”的公司，认为另一只股票上涨75%还“没有结束”
Photo: Shutterstock
Photo: shutterstock
